Robert A Neurath

Title: The Innovations of Robert A. Neurath

Introduction

Robert A. Neurath is a notable inventor based in New York, NY, who has made significant contributions to the field of immunization. With a total of three patents to his name, he has focused on developing vaccines that target viral hepatitis. His work has been instrumental in advancing public health through innovative vaccine solutions.

Latest Patents

Neurath's latest patents include a vaccine for active immunization containing hepatitis B surface antigen. This vaccine is designed to combat viral hepatitis effectively. Another significant patent involves a process for preparing a vaccine that contains unprecipitated filaments and hepatitis B Dane particle specific antigens. This process ensures the removal of other proteinaceous matter from blood serum, resulting in a serum that contains less than 10% proteinaceous matter unrelated to hepatitis B surface antigen. Additionally, any virus present is inactivated, and the antigenic mass is diluted with a physiologically acceptable medium.

Career Highlights

Neurath has had a distinguished career, working at the New York Blood Center, Inc. His role at this esteemed institution has allowed him to focus on research and development in the field of immunology. His contributions have not only advanced scientific knowledge but have also had a direct impact on public health initiatives.

Collaborations

Throughout his career, Neurath has collaborated with esteemed colleagues, including Alfred M. Prince and John Vnek. These collaborations have fostered an environment of innovation and have led to significant advancements in vaccine development.

Conclusion

Robert A. Neurath's work in vaccine development has made a lasting impact on the field of immunization. His innovative patents and collaborations highlight his commitment to improving public health through scientific research. His contributions continue to be relevant in the ongoing fight against viral diseases.